Literature DB >> 7618235

Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone protein matrix.

B Dussol1, S Geider, A Lilova, F Léonetti, P Dupuy, M Daudon, Y Berland, J C Dagorn, J M Verdier.   

Abstract

Our aims were to analyze the protein composition of the organic matrix of urinary stones and to investigate the role of albumin in its constitution. Five different morphological types of stones were studied. Proteins extracted from the stone were submitted to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by immunoblotting with antibodies to 13 urinary proteins. Nine of the 13 proteins were found in all types of stone: human serum albumin (HSA), alpha 1-acid glycoprotein (alpha 1-GP), alpha 1-microglobulin (alpha 1-M), immunoglobulins (Igs), apolipoprotein A1 (apo-A1), transferrin (Tr), alpha 1-antitrypsin (alpha 1-T), retinol-binding protein (RBP) and renal lithostathine (RL). The beta 2-microglobulin (beta 2-M) was present only in calcium oxalate and uric acid stones. In contrast, ceruloplasmin, haptoglobin and Tamm-Horsfall protein (THP) were detected in none of them. Because HSA appeared as the major protein component in all stones, we wondered whether it might play a specific role in the constitution of the stone matrix. Association of HSA with urinary proteins that were present in stones was demonstrated by showing that proteins present in the matrix comigrated with HSA on gel filtration, whereas proteins that were absent did not. Moreover, HSA induced the binding of stone matrix proteins to an albumin-specific affinity column. Finally, we evidenced HSA binding to calcium oxalate monohydrate (COM) crystals in a solution similar to urine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7618235     DOI: 10.1007/BF00298850

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  30 in total

1.  FURTHER STUDIES OF MATRIX SUBSTANCE A.

Authors:  H J KEUTEL; J S KING
Journal:  Invest Urol       Date:  1964-09

2.  Crystal-matrix interrelations in calculi.

Authors:  W H BOYCE; J S KING
Journal:  J Urol       Date:  1959-03       Impact factor: 7.450

Review 3.  Protein inhibitors of crystallization.

Authors:  F I Coe; J H Parks; Y Nakagawa
Journal:  Semin Nephrol       Date:  1991-03       Impact factor: 5.299

4.  Urinary Tamm-Horsfall glycoprotein in certain kidney diseases and its content in renal and bladder calculi.

Authors:  A M Grant; L R Baker; A Neuberger
Journal:  Clin Sci       Date:  1973-04       Impact factor: 6.124

Review 5.  Serum albumin.

Authors:  T Peters
Journal:  Adv Protein Chem       Date:  1985

Review 6.  Currents in renal stone research.

Authors:  J S King
Journal:  Clin Chem       Date:  1971-10       Impact factor: 8.327

7.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.

Authors:  B Hess; Y Nakagawa; F L Coe
Journal:  Am J Physiol       Date:  1989-07

8.  Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones.

Authors:  P R Harvey; G A Upadhya; S M Strasberg
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

9.  Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.

Authors:  Y Nakagawa; M Ahmed; S L Hall; S Deganello; F L Coe
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

10.  Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth.

Authors:  J M Verdier; B Dussol; P Casanova; M Daudon; P Dupuy; P Berthezene; R Boistelle; Y Berland; J C Dagorn
Journal:  Eur J Clin Invest       Date:  1992-07       Impact factor: 4.686

View more
  20 in total

1.  Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis.

Authors:  Peter A Cadieux; Darren T Beiko; James D Watterson; Jeremy P Burton; Jeffrey C Howard; Bodo E Knudsen; Bing Siang Gan; John K McCormick; Ann F Chambers; John D Denstedt; Gregor Reid
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Guaifenesin stone matrix proteomics: a protocol for identifying proteins critical to stone formation.

Authors:  A M Kolbach-Mandel; N S Mandel; S R Cohen; J G Kleinman; F Ahmed; I C Mandel; J A Wesson
Journal:  Urolithiasis       Date:  2016-07-19       Impact factor: 3.436

3.  In vitro crystallisation systems for the study of urinary stone formation.

Authors:  W Achilles
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Modification of calcite crystal growth by abalone shell proteins: an atomic force microscope study.

Authors:  D A Walters; B L Smith; A M Belcher; G T Paloczi; G D Stucky; D E Morse; P K Hansma
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

Review 5.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

6.  Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal.

Authors:  Ann M Kolbach-Mandel; Neil S Mandel; Brian R Hoffmann; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urolithiasis       Date:  2017-03-17       Impact factor: 3.436

7.  In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.

Authors:  Cary A Kuliasha; Douglas Rodriguez; Archana Lovett; Laurie B Gower
Journal:  CrystEngComm       Date:  2020-02-05       Impact factor: 3.545

8.  Models for protein binding to calcium oxalate surfaces.

Authors:  Asiya Gul; Peter Rez
Journal:  Urol Res       Date:  2007-03-20

9.  Inhibition of calcium oxalate crystallization by commercial human serum albumin and human urinary albumin isolated from two different race groups: evidence for possible molecular differences.

Authors:  Allen L Rodgers; Priscilla D Mensah; Sylva L Schwager; Edward D Sturrock
Journal:  Urol Res       Date:  2006-12

10.  Surface aggregation of urinary proteins and aspartic Acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy.

Authors:  Matthew L Weaver; S Roger Qiu; John R Hoyer; William H Casey; George H Nancollas; James J De Yoreo
Journal:  Calcif Tissue Int       Date:  2009-03-18       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.